422 related articles for article (PubMed ID: 14648806)
1. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
Biessels GJ; ter Laak MP; Kamal A; Gispen WH
Brain Res; 2005 Feb; 1035(1):86-93. PubMed ID: 15713280
[TBL] [Abstract][Full Text] [Related]
3. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment.
Biessels GJ; Cristino NA; Rutten GJ; Hamers FP; Erkelens DW; Gispen WH
Brain; 1999 Apr; 122 ( Pt 4)():757-68. PubMed ID: 10219786
[TBL] [Abstract][Full Text] [Related]
4. L-carnitine treatment improves brain stem auditory evoked potentials in diabetic rats.
Yildiz O; Ozata M; Ozkardeş A; Corakçi A; Gündoğan N; Gündoğan MA
Neuroreport; 1996 Nov; 7(18):2957-9. PubMed ID: 9116218
[TBL] [Abstract][Full Text] [Related]
5. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats.
Mizisin AP; Calcutt NA; Tomlinson DR; Gallagher A; Fernyhough P
J Peripher Nerv Syst; 1999; 4(3-4):211-21. PubMed ID: 10642089
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Robertson S
Diabetologia; 1992 Jan; 35(1):12-8. PubMed ID: 1371757
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
[TBL] [Abstract][Full Text] [Related]
9. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
Inkster ME; Cotter MA; Cameron NE
Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
[TBL] [Abstract][Full Text] [Related]
10. Novel protein kinase C-beta isoform selective inhibitor JTT-010 ameliorates both hyper- and hypoalgesia in streptozotocin- induced diabetic rats.
Sasase T; Yamada H; Sakoda K; Imagawa N; Abe T; Ito M; Sagawa S; Tanaka M; Matsushita M
Diabetes Obes Metab; 2005 Sep; 7(5):586-94. PubMed ID: 16050952
[TBL] [Abstract][Full Text] [Related]
11. Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats.
Crespo MJ; Dunbar DC
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1311-8. PubMed ID: 14984003
[TBL] [Abstract][Full Text] [Related]
12. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
Nangle MR; Gibson TM; Cotter MA; Cameron NE
Planta Med; 2006 May; 72(6):494-500. PubMed ID: 16773532
[TBL] [Abstract][Full Text] [Related]
13. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sayyed SG; Kumar A; Sharma SS
Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats.
Hasegawa T; Kosaki A; Shimizu K; Matsubara H; Mori Y; Masaki H; Toyoda N; Inoue-Shibata M; Nishikawa M; Iwasaka T
Exp Neurol; 2006 Jun; 199(2):274-80. PubMed ID: 16337192
[TBL] [Abstract][Full Text] [Related]
15. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].
Han LP; Yu DM; Xie Y
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2513-5. PubMed ID: 19080636
[TBL] [Abstract][Full Text] [Related]
16. Independent alterations in the central and peripheral somatosensory pathways in rat diabetic neuropathy.
Piriz J; Torres-Aleman I; Nuñez A
Neuroscience; 2009 May; 160(2):402-11. PubMed ID: 19264110
[TBL] [Abstract][Full Text] [Related]
17. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N
J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455
[TBL] [Abstract][Full Text] [Related]
18. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
Cameron NE; Cotter MA
Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573
[TBL] [Abstract][Full Text] [Related]
19. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
Davidson EP; Holmes A; Coppey LJ; Yorek MA
Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
[TBL] [Abstract][Full Text] [Related]
20. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sharma SS; Sayyed SG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
